Hill A, Moyle G. Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med 2007; 8: 259-264. Methodological accuracy in cross-trial comparisons of antiretroviral regimens in multitreated patients

HIV Med. 2007 Nov;8(8):568-70; author reply 571-2. doi: 10.1111/j.1468-1293.2007.00503.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Male
  • Pyridines / therapeutic use
  • Pyrones / therapeutic use
  • RNA, Viral
  • Ritonavir / therapeutic use
  • Sulfonamides
  • Treatment Outcome

Substances

  • HIV Protease Inhibitors
  • Pyridines
  • Pyrones
  • RNA, Viral
  • Sulfonamides
  • Ritonavir
  • tipranavir